Carregant...
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
Glioblastoma (GBM) is a highly malignant type of primary brain tumor with a high mortality rate. Although the current standard therapy consists of surgery followed by radiation and temozolomide (TMZ), chemotherapy can extend patient’s post-operative survival but most cases eventually demonstrate res...
Guardat en:
| Publicat a: | Neurol Med Chir (Tokyo) |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Japan Neurosurgical Society
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6186761/ https://ncbi.nlm.nih.gov/pubmed/30249919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2176/nmc.ra.2018-0141 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|